Drugs / [18F]FPEB
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00870974 | Mar 2009 → Oct 2016 | Alzheimer disease, Huntington disease, Parkinson disease, autism spectrum disorder +2 | Institute for Neurodegenerative Disorders | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [18F]FPEB | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00870974 ↗ |
| Modality | Diagnostic / imaging agent | “positron emission tomography (PET) imaging” NCT00870974 ↗ |
| Route | Other | “bolus injection” NCT00870974 ↗ |